SOLJULI

Serial Number 88662039
606

Registration Progress

Application Filed
Oct 21, 2019
Under Examination
May 26, 2020
Approved for Publication
Mar 31, 2020
Published for Opposition
Mar 31, 2020
Registered

Trademark Image

SOLJULI

Basic Information

Serial Number
88662039
Filing Date
October 21, 2019
Published for Opposition
March 31, 2020
Abandonment Date
June 26, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 26, 2023
Classes
005

Rights Holder

Lupin Limited

99
Address
Bandra Kurla Complex; Bandra (W) B/4
Laxmi Towers
Mumbai 400051
IN

Ownership History

Lupin Limited

Original Applicant
99
Mumbai IN

Lupin Limited

Owner at Publication
99
Mumbai IN

Legal Representation

Attorney
Robert L. Powley

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description Documents
Jun 26, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 26, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 29, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 28, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 26, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 26, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 3, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 2, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 2, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 26, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
May 26, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 26, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 26, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 26, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 4, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 30, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 30, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 30, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 5, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 3, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 3, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 3, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 26, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 31, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 31, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 11, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 27, 2020 ALIE A ASSIGNED TO LIE Loading...
Feb 21, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 29, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 29, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 29, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 27, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 24, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 24, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapies; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation

Classification

International Classes
005